Our research team focuses on the use of high-throughput omics technologies to elucidate the molecular etiology of genetic diseases including cancers, neurodevelopmental and neuropsychiatric disorders. To facilitate the development of precision cancer medicine, we also operate a centralized tumor biobank facility, which is a subsidiary of the Ramathibodi comprehensive cancer center. In addition, we have co-developed the Thai copy number variation (Thai CNV) database, and run the Ramathibodi clinical chromosomal microarray laboratory. The ultimate goal is to translate our research findings into new preventive and therapeutic strategies together with our collaborators who represent a team of dedicated clinicians and scientists across multiple disciplines.